Fexofenadine hydrochloride vs Mepolizumab
National NHS prescribing compared (Prescription Cost Analysis)
Fexofenadine hydrochloride was dispensed 783,732.0× as often as Mepolizumab in June 2026 — 783,732 items versus 1 in England.
783,732items
Fexofenadine hydrochloride · June 2026
NHSBSA Prescription Cost Analysis
1items
Mepolizumab · June 2026
NHSBSA Prescription Cost Analysis
Figure 1. Fexofenadine hydrochloride versus Mepolizumab: national items dispensed by month
▬ Fexofenadine hydrochloride · ╌ Mepolizumab
Source: NHSBSA Prescription Cost Analysis, to June 2026
| Measure | Fexofenadine hydrochloride | Mepolizumab |
|---|---|---|
| Items, June 2026 | 783,732 | 1 |
| Items, last 12 months | 7,188,922 | 2 |
| Net ingredient cost, June 2026 | £3,018,300 | £3,360 |
See the full profile for Fexofenadine hydrochloride or Mepolizumab.